Literature DB >> 3348841

Atherogenesis in two strains of obese rats. The fatty Zucker and LA/N-corpulent.

R M Amy1, P J Dolphin, R A Pederson, J C Russell.   

Abstract

Two strains of obese rats, the fatty Zucker and the LA/N-corpulent have been compared at 6 months age for the presence of vascular and myocardial disease. Both strains, when obese, exhibit a VLDL hyperlipidemia with elevated triglycerides and moderate elevations of plasma cholesterol concentrations compared to the lean rats of the same strain. The hyperlipidemia is more modest in the fatty Zucker than the corpulent LA/N, and the serum lipid concentrations of the lean Zucker are lower than those of the lean LA/N. Apolipoprotein concentrations were similar and elevated in the two obese genotypes compared to the lean genotypes which were also similar to each other. Male and female obese animals of both strains exhibited hyperinsulinemia under fasting conditions and after oral glucose, with obese male LA/N rats exhibiting the most severe hyperinsulinemia. Glucose tolerance was impaired in obese LA/N animals but was normal in lean rats of both strains and fatty Zucker rats of both sexes. The glucose intolerance observed in obese LA/N animals was more severe in the male than in the female rats. Unlike the corpulent rat, which develops atherosclerotic lesions, the fatty Zucker shows no evidence of advanced vascular lesions on scanning electron microscopy. The fatty Zucker also does not develop the myocardial lesions that are frequent in the male corpulent LA/N rat. It is suggested that the initiation of the atherogenic process is dependent upon elevated insulin levels or transient hyperglycemia. Development of the advanced lesions appears to require the presence of hyperlipidemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348841     DOI: 10.1016/0021-9150(88)90015-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

Review 1.  Obesity and Cardiometabolic Defects in Heart Failure Pathology.

Authors:  Ganesh V Halade; Vasundhara Kain
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

2.  Sustained decreases in weight and serum insulin, glucose, triacylglycerol and cholesterol in JCR:LA-corpulent rats treated with D-fenfluramine.

Authors:  D N Brindley; P Hales; A I al-Sieni; J C Russell
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 3.  Cardiovascular disease in the JCR:LA-cp rat.

Authors:  J C Russell; S E Graham; M Richardson
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 4.  Rat models for bariatric surgery and surgery for type 2 diabetes mellitus.

Authors:  Sheetal Bharat Mistry; Juan J Omana; Subhash Kini
Journal:  Obes Surg       Date:  2009-03-06       Impact factor: 4.129

5.  Glucose tolerance, lipids, and GLP-1 secretion in JCR:LA-cp rats fed a high protein fiber diet.

Authors:  Raylene A Reimer; James C Russell
Journal:  Obesity (Silver Spring)       Date:  2008-01       Impact factor: 5.002

6.  Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation.

Authors:  Xueliang Du; Diane Edelstein; Silvana Obici; Ninon Higham; Ming-Hui Zou; Michael Brownlee
Journal:  J Clin Invest       Date:  2006-03-09       Impact factor: 14.808

7.  Differential impact of dilator stimuli on increased myogenic activation of cerebral and skeletal muscle resistance arterioles in obese zucker rats.

Authors:  Joshua T Butcher; Adam G Goodwill; Shyla C Stanley; Jefferson C Frisbee
Journal:  Microcirculation       Date:  2013-10       Impact factor: 2.628

Review 8.  Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.

Authors:  Bingxuan Wang; P Charukeshi Chandrasekera; John J Pippin
Journal:  Curr Diabetes Rev       Date:  2014-03

9.  The 14th Ile residue is essential for Leptin function in regulating energy homeostasis in rat.

Authors:  Shuyang Xu; Xianmin Zhu; Hong Li; Youtian Hu; Jinping Zhou; Di He; Yun Feng; Lina Lu; Guizhen Du; Youjin Hu; Tiancheng Liu; Zhen Wang; Guohui Ding; Jiayu Chen; Shaorong Gao; Fang Wu; Zhigang Xue; Yixue Li; Guoping Fan
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.